As an example, the pharmacological blockade of the glutamine amino acid transporter ASCT2 using the inhibitor V-9302 results in attenuated cancer cell growth and proliferation, enhanced cell death, and increased oxidative stress, and these effects collectively contribute to anti-tumour responses in vitro and in vivo [37]. This evidence concerns the gene SLC1A5 and neoplasm.